SEC Form 4 · accession 0001179110-17-010115
MERIT MEDICAL SYSTEMS INC · MMSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard W Edelman
Other
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000856982
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par ValueF1 | Jun 30, 2017 | M | 20,000 | $9.95 | A | 35,000 | D | |
| Common Stock, No Par ValueF1,F2 | Jun 30, 2017 | S | 20,000 | $37.619 | D | 15,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock options (right to buy)F5 | $9.95 | Jun 30, 2017 | M | 20,000 | D | May 22, 2014 | May 22, 2020 | Common Stock | 20,000 | 0 | D |
| Non-qualified stock options (right to buy)F3 | $13.75 | holding | — | — | — | Aug 11, 2012 | Aug 11, 2018 | Common Stock | 20,000 | 20,000 | D |
| Non-qualified stock options (right to buy)F4 | $12.91 | holding | — | — | — | May 23, 2013 | May 23, 2019 | Common Stock | 20,000 | 20,000 | D |
| Non-qualified stock options (right to buy)F6 | $13.99 | holding | — | — | — | Jun 11, 2015 | Jun 11, 2021 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F7 | $20.27 | holding | — | — | — | May 22, 2016 | May 22, 2022 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F8 | $18.80 | holding | — | — | — | May 26, 2017 | May 26, 2023 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The reporting person ceased to be a director of the Issuer on May 24, 2017.
- F2The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.53 to 37.80, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3Became exercisable in equal annual installments of 20% commencing 08/11/2012.
- F4Became exercisable in equal annual installments of 20% commencing 05/23/2013.
- F5Became exercisable in equal annual installments of 20% commencing 05/22/2014. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
- F6Became exercisable in equal annual installments of 20% commencing 06/11/2015. Installments scheduled for vesting after 6/11/2017 will not be exercisable.
- F7Became exercisable in equal annual installments of 20% commencing 05/22/2016. Installments scheduled for vesting after 5/22/2017 will not be exercisable.
- F8Became exercisable in equal annual installments of 20% commencing 05/26/2017. Installments scheduled for vesting after 5/26/2017 will not be exercisable.